After being referred by their physician, Medicare patients wait an average of 34 days to see a neurologist, according to ...

Hartford HealthCare and Aidoc today announced the launch of a new partnership to innovate and integrate tailored clinical ...

EEG-based emotional analysis achieves near-perfect accuracy in Parkinson’s diagnosis, offering a non-invasive, objective ...

Widely recognized as the global benchmark for nursing excellence, the award highlights the hospital's commitment to ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve diagnosis and treatment of neurological disorders and early-stage cancer, today announced the ...

Curacity, hospitality's leading media brand network that powered over $500M in validated hotel bookings in 2024, launches two new solutions: Content Hub and Insights Hub. These innovative hubs ...

EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Agreement Newron and Myung In Pharm announce license agreement for evenamide in South Korea 09.01.2025 / 07:00 CET/CEST The issuer is solely ...

Spinal Devices Market. The global spinal devices market is set to witness remarkable expansion, projected to grow at a CAGR ...

Rough Draft presents our 16th annual 20 Under 20 honorees for 2025. As in past years, we are in awe of these students’ ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...